Firm Building Psychedelic Life Chain Ships First Order to New Partner

Firm Building Psychedelic Life Chain Ships First Order to New Partner

By: Tomas Ronolski - AllPennyStocks.com News

Monday, May 2, 2022

The use of psychedelics for mental health treatment is seeing growing acceptance. This biotechnology company is developing innovative products and therapies and a full supply chain of naturally derived psychedelics.  

Biotechnology firm AVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) successfully shipped its first order of white label natural health products to their Australian distribution partner, Woke Pharmaceuticals Pty Ltd, per its recent press release. AVN works on the standardized extraction of psychoactive compounds and the development of natural health products. 

The distribution agreement  was signed late last year and allows AVN’s white label products to be available through Australian retailers, including major supermarkets and other retail outlets, as well as Australia and New Zealand Amazon sites.

Canadian shares were trading up over 7 percent in early morning trade.

 


Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Shares on the Rise Following Partnership News With Major Potato Chip Brand
Slowing Growth Increases Hopes of a Rate Cut Pivot in Canada 
Re-Classification of Marijuana Sends Shares of Cannabis Operator on a Tear
Most Popular
FREE Newsletter


Back to Top